Skip Navigation

Brain 2006 129(11):2805-2807; doi:10.1093/brain/awl281
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Klunk, W. E.
Right arrow Articles by DeKosky, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klunk, W. E.
Right arrow Articles by DeKosky, S. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Scientific Commentaries

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease

William E. Klunk, Chester A. Mathis, Julie C. Price, Brian J. Lopresti and Steven T. DeKosky

University of Pittsburgh Medical School Pittsburgh, MA, USA

E-mail: klunkwe@upmc.edu

The first 150 words of the full text of this article appear below.

Understanding the natural history of amyloid deposition is of great importance for advancing our knowledge of the pathophysiology of Alzheimer's disease—both during the clinically apparent phase as well as during the antecedent pre-clinical phase (Goldman et al., 2001Go). Awareness of the natural history of amyloid deposition also will be necessary to interpret experimental anti-amyloid drug studies that might extend over a year or more. Post-mortem studies cannot, of course, directly assess the progression of amyloid deposition in an individual over time and attempts to deduce the natural history by comparing a series of post-mortem cases with different clinical severities and amyloid loads have significant limitations (Hyman and Gomez-Isla, 1997Go). Nevertheless, several very extensive post-mortem studies have provided useful information (Braak and Braak, 1997Go). For example, although some degree of correlation has been reported between plaque load (Cummings et al., 1996Go) or Aß levels (Naslund . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
T. Hedden, K. R. A. Van Dijk, J. A. Becker, A. Mehta, R. A. Sperling, K. A. Johnson, and R. L. Buckner
Disruption of Functional Connectivity in Clinically Normal Older Adults Harboring Amyloid Burden
J. Neurosci., October 7, 2009; 29(40): 12686 - 12694.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
C. Davatzikos, F. Xu, Y. An, Y. Fan, and S. M. Resnick
Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index
Brain, August 1, 2009; 132(8): 2026 - 2035.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
W. E. Klunk, J. C. Price, C. A. Mathis, N. D. Tsopelas, B. J. Lopresti, S. K. Ziolko, W. Bi, J. A. Hoge, A. D. Cohen, M. D. Ikonomovic, et al.
Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees
J. Neurosci., June 6, 2007; 27(23): 6174 - 6184.
[Abstract] [Full Text] [PDF]